HOME   |    PDF   |   


Title

Evaluation of salivary circulating tumor DNA for early diagnosis and detection of oral cancer: A case-control study

 

Authors

Sanjeev Laller 1, Anuj Gaba 2, Satwik Chatterjee 3, Anupam Tiwary 4, Hemant Sawhney 5,* & Sameer Gupta 6

 

Affiliation

1Department of Dentistry, Miri Piri Institute of Medical Sciences and Research Centre, Shahbad, Kurukshetra, Haryana, India; 2Department of Forensic Medicine and Toxicology, AIIMS Kalyani, West Bengal, India; 3Department of Forensic Science, Adamas University, Kolkata, West Bengal, India; 4Consultant Oral & Maxillofacial Surgeon and Independent Researcher, Ranchi , India 5Department of Oral Medicine and Radiology, School of Dental Sciences, Sharda University, Greater Noida, Uttar Pradesh, India; 6Department of Oral & Maxillofacial Surgery, Inderprastha Dental College and Hospital, Sahibabad, Ghaziabad, Uttar Pradesh, India; *Corresponding author

 

Email

Sanjeev Laller - E-mail: drlallersanjeev@gmail.com
Anuj Gaba - E- mail: anuj.gaba989@gmail.com
Satwik Chatterjee - Email: drsatwikc356@gmail.com
Anupam Tiwary - Email: dranupamshandilya@gmail.com
Hemant Sawhney - Email: hemant.sawhney@sharda.ac.in
Sameer Gupta - Email: sameer.gupta83@yahoo.in
 

Article Type

Research Article

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Oral squamous cell carcinoma (OSCC) is often diagnosed at an advanced stage, highlighting the need for non-invasive biomarkers for early detection. Therefore, it is of interest to evaluate the salivary circulating tumor DNA (ctDNA), TP53 mutation status and p16 promoter methylation in 100 participants, including 50 OSCC cases and 50 controls. Mean salivary ctDNA was significantly higher in OSCC cases than controls (50.54  +/-  16.21 vs 8.99  +/-  3.31 ng/µL, p<0.001), with an AUC of 0.9996. At a 20 ng/µL cut-off, ctDNA showed 84.0% sensitivity, 96.0% specificity and 90.0% diagnostic accuracy, while TP53 mutations and p16 methylation were significantly more frequent in OSCC cases. Thus, data support salivary ctDNA as a promising minimally invasive biomarker for OSCC detection and warrant validation in larger prospective cohorts, including premalignant lesions.

 

Keywords

Salivary circulating tumor DNA (ctDNA), oral squamous cell carcinoma (OSCC), liquid biopsy, TP53 mutation, p16 promoter methylation, case-control study

 

Citation

Laller et al. Bioinformation 22(10): 6820-6824 (2026)

 

Edited by

Ruby Singh

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.